Literature DB >> 8893010

Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

G Lagna1, A Hata, A Hemmati-Brivanlou, J Massagué.   

Abstract

The TGF-beta/activin/BMP superfamily of growth factors signals through heteromeric receptor complexes of type I and type II serine/threonine kinase receptors. The signal originated by TGF-beta-like molecules appears to be transduced by a set of evolutionarily conserved proteins known as SMADs, which upon activation directly translocate to the nucleus where they may activate transcription. Five SMAD proteins have so far been characterized in vertebrates. These factors are related to the mediator of decapentaplegic (dpp) signalling, mothers against dpp (Mad), in Drosophila and to the Sma genes from Caenorhabditis elegans. Smad1 and Smad2 have been shown to mimic the effects of BMP and activin, respectively, both in Xenopus and in mammalian cells, whereas Smad3 (a close homologue of Smad2) and the related protein DPC4, a tumour-suppressor gene product, mediate TGF-beta actions. We report here that DPC4 is essential for the function of Smad1 and Smad2 in pathways that signal mesoderm induction and patterning in Xenopus embryos, as well as antimitogenic and transcriptional responses in breast epithelial cells. DPC4 associates with Smad1 in response to BMP and with Smad2 in response to activin or TGF-beta. DPC4 is therefore a regulated partner of SMADs that function in different signalling pathways of the TGF-beta family.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8893010     DOI: 10.1038/383832a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  211 in total

1.  Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase.

Authors:  Y Zhang; C Chang; D J Gehling; A Hemmati-Brivanlou; R Derynck
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

Review 2.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

3.  PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway.

Authors:  M Tan; Y Wang; K Guan; Y Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 4.  The Spemann organizer and embryonic head induction.

Authors:  C Niehrs
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

5.  A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation.

Authors:  Z Xiao; X Liu; Y I Henis; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

6.  A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction.

Authors:  R H Kim; D Wang; M Tsang; J Martin; C Huff; M P de Caestecker; W T Parks; X Meng; R J Lechleider; T Wang; A B Roberts
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

7.  Structural basis for the functional difference between Smad2 and Smad3 in FAST-2 (forkhead activin signal transducer-2)-mediated transcription.

Authors:  R P Nagarajan; Y Chen
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

8.  Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1.

Authors:  I Shin; A V Bakin; U Rodeck; A Brunet; C L Arteaga
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

9.  An allelic series of mutations in Smad2 and Smad4 identified in a genotype-based screen of N-ethyl-N- nitrosourea-mutagenized mouse embryonic stem cells.

Authors:  Jay L Vivian; Yijing Chen; Della Yee; Elizabeth Schneider; Terry Magnuson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-13       Impact factor: 11.205

10.  Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.

Authors:  R P Nagarajan; F Chen; W Li; E Vig; M A Harrington; H Nakshatri; Y Chen
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.